Alternative splicing of the ADAR1 transcript in a region that functions either as a 5′-UTR or an ORF

RNA

Volumn 13, Issue 10, 2007, Pages 1732-1744

  Lykke Andersen, Søren ^a   Piñol Roma, Serafín ^b   Kjems, Jørgen ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

ADAR; Alternative splicing; Retained intron

Indexed keywords

ADENOSINE; MESSENGER RNA; PROTEIN; PROTEIN ADAR1; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADAR1 GENE; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DEAMINATION; EXON; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRON; METAZOON; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; ADENOSINE DEAMINASE; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; INTRONS; MICE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PRIMATES; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS;

METAZOA; PRIMATES;

EID: 34748861951     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.567807     Document Type: Article

References (51)

1. Bass, B.L. 2002. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71: 817-846.
2. Buhler, M., Steiner, S., Mohn, F., Paillusson, A., and Muhlemann, O. 2006. EJC-independent degradation of nonsense immunoglobulin-mu mRNA depends on 3′-UTR length. Nat. Struct. Mol. Biol. 13: 462-464.
3. Cramer, P., Caceres, J.F., Cazalla, D., Kadener, S., Muro, A.F., Baralle, F.E., and Kornblihtt, A.R. 1999. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol. Cell 4: 251-258.
4. Dabiri, G.A., Lai, F., Drakas, R.A., and Nishikura, K. 1996. Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase. EMBO J. 15: 34-45.
5. Der, S.D., Zhou, A., Williams, B.R., and Silverman, R.H. 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. 95: 15623-15628.
6. Desterro, J.M., Keegan, L.P., Lafarga, M., Berciano, M.T., O'Connell, M., and Carmo-Fonseca, M. 2003. Dynamic association of RNA-editing enzymes with the nucleolus. J. Cell Sci. 116: 1805-1818.
7. Feng, Y., Sansam, C.L., Singh, M., and Emeson, R.B. 2006. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol. Cell. Biol. 26: 480-488.
8. Gebauer, F., Merendino, L., Hentze, M.W., and Valcarcel, J. 1998. The Drosophila splicing regulator sex-lethal directly inhibits translation of male-specific-lethal 2 mRNA. RNA 4: 142-150.
9. George, C.X. and Samuel, C.E. 1999a. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229: 203-213.
10. George, C.X. and Samuel, C.E. 1999b. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl. Acad. Sci. 96: 4621-4626.
11. George, C.X., Wagner, M.V., and Samuel, C.E. 2005. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J. Biol. Chem. 280: 15020-15028.
12. Gerber, A., O'Connell, M.A., and Keller, W. 1997. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3: 453-463.
13. Green, R.E., Lewis, B.P., Hillman, R.T., Blanchette, M., Lareau, L.F., Garnett, A.T., Rio, D.C., and Brenner, S.E. 2003. Widespread predicted nonsense-mediated mRNA decay of alternatively spliced transcripts of human normal and disease genes. Bioinformatics (Suppl 1) 19: i118-i121.
14. Hartner, J.C., Schmittwolf, C., Kispert, A., Muller, A.M., Higuchi, M., and Seeburg, P.H. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 279: 4894-4902.
15. Higuchi, M., Maas, S., Single, F.N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., and Seeburg, P.H. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406: 78-81.
16. Hurst, S.R., Hough, R.F., Aruscavage, P.J., and Bass, B.L. 1995. Deamination of mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deaminase: Similarities to in vivo RNA editing. RNA 1: 1051-1060.
17. Kadener, S., Cramer, P., Nogues, G., Cazalla, D., de la Mata, M., Fededa, J.P., Werbajh, S.E., Srebrow, A., and Kornblihtt, A.R. 2001. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J. 20: 5759-5768.
18. Kawakubo, K. and Samuel, C.E. 2000. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 258: 165-172.
19. Keegan, L.P., Leroy, A., Sproul, D., and O'Connell, M.A. 2004. Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes. Genome Biol. 5: 209.
20. Kim, U., Wang, Y., Sanford, T., Zeng, Y., and Nishikura, K. 1994. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. 91: 11457-11461.
21. Lai, F., Chen, C.X., Carter, K.C., and Nishikura, K. 1997. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol. Cell. Biol. 17: 2413-2424.
22. Lewis, B.P., Green, R.E., and Brenner, S.E. 2003. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. 100: 189-192.
23. Liu, Y., George, C.X., Patterson, J.B., and Samuel, C.E. 1997. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272: 4419-4428.
24. Lykke-Andersen, J., Shu, M.D., and Steitz, J.A. 2000. Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 103: 1121-1131.
25. Maas, S., Patt, S., Schrey, M., and Rich, A. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. 98: 14687-14692.
26. Maas, S., Rich, A., and Nishikura, K. 2003. A-to-I RNA editing: Recent news and residual mysteries. J. Biol. Chem. 278: 1391-1394.
27. Maquat, L.E. 2004. Nonsense-mediated mRNA decay: Splicing, translation, and mRNP dynamics. Nat. Rev. Mol. Cell Biol. 5: 89-99.
28. Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P.H., and Higuchi, M. 1996. A mammalian RNA editing enzyme. Nature 379: 460-464.
29. Mendell, J.T., Rhys, C.M., and Dietz, H.C. 2002. Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts. Science 298: 419-422.
30. Mili, S., Shu, H.J., Zhao, Y., and Pinol-Roma, S. 2001. Distinct RNP complexes of shuttling hnRNP proteins with pre-mRNA and mRNA: Candidate intermediates in formation and export of mRNA. Mol. Cell. Biol. 21: 7307-7319.
31. Mittaz, L., Scott, H.S., Rossier, C., Seeburg, P.H., Higuchi, M., and Antonarakis, S.E. 1997. Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3. Genomics 41: 210-217.
32. O'Connell, M.A., Krause, S., Higuchi, M., Hsuan, J.J., Totty, N.F., Jenny, A., and Keller, W. 1995. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15: 1389-1397.
33. Pan, Q., Saltzman, A.L., Kim, Y.K., Misquitta, C., Shai, O., Maquat, L.E., Frey, B.J., and Blencowe, B.J. 2006. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes & Dev. 20: 153-158.
34. Patterson, J.B. and Samuel, C.E. 1995. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: Evidence for two forms of the deaminase. Mol. Cell. Biol. 15: 5376-5388.
35. Patterson, J.B., Thomis, D.C., Hans, S.L., and Samuel, C.E. 1995. Mechanism of interferon action: Double-stranded RNA-specific adenosine deaminase from human cells is inducible by α and γ interferons. Virology 210: 508-511.
36. Pinol-Roma, S., Choi, Y.D., Matunis, M.J., and Dreyfuss, G. 1988. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes & Dev. 2: 215-227.
37. Polson, A.G., Bass, B.L., and Casey, J.L. 1996. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380: 454-456.
38. Poulsen, H., Nilsson, J., Damgaard, C.K., Egebjerg, J., and Kjems, J. 2001. CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol. Cell. Biol. 21: 7862-7871.
39. Rueter, S.M., Dawson, T.R., and Emeson, R.B. 1999. Regulation of alternative splicing by RNA editing. Nature 399: 75-80.
40. Sato, S., Wong, S.K., and Lazinski, D.W. 2001. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 75: 8547-8555.
41. Silva, A.L., Pereira, F.J., Morgado, A., Kong, J., Martins, R., Faustino, P., Liebhaber, S.A., and Romao, L. 2006. The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context. RNA 12: 2160-2170.
42. Slavov, D. and Gardiner, K. 2002. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: Conservation and diversity in editing site sequence and alternative splicing patterns. Gene 299: 83-94.
43. Thanaraj, T.A. and Clark, F. 2001. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res. 29: 2581-2593.
44. Valente, L. and Nishikura, K. 2005. ADAR gene family and A-to-I RNA editing: Diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 79: 299-338.
45. Wang, Y., Zeng, Y., Murray, J.M., and Nishikura, K. 1995. Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: The enzyme for glutamate-activated ion channel RNA editing. J. Mol. Biol. 254: 184-195.
46. Wang, Q., Khillan, J., Gadue, P., and Nishikura, K. 2000. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290: 1765-1768.
47. Wang, Q., Miyakoda, M., Yang, W., Khillan, J., Stachura, D.L., Weiss, M.J., and Nishikura, K. 2004. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 279: 4952-4961.
48. Weier, H.U., George, C.X., Greulich, K.M., and Samuel, C.E. 1995. The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. Genomics 30: 372-375.
49. Wong, S.K. and Lazinski, D.W. 2002. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc. Natl. Acad. Sci. 99: 15118-15123.
50. Wong, S.K., Sato, S., and Lazinski, D.W. 2001. Substrate recognition by ADAR1 and ADAR2. RNA 7: 846-858.
51. Wong, S.K., Sato, S., and Lazinski, D.W. 2003. Elevated activity of the large form of ADAR1 in vivo: Very efficient RNA editing occurs in the cytoplasm. RNA 9: 586-598.